Australia markets open in 34 minutes

Larimar Therapeutics, Inc. (LRMR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.09+0.61 (+9.41%)
At close: 04:00PM EDT
7.24 +0.15 (+2.12%)
After hours: 06:25PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
23,324
27,670
24,250
38,396
31,407
Selling general and administrative
11,849
14,088
12,276
12,069
11,397
Total operating expenses
35,173
41,758
36,526
50,465
42,804
Operating income or loss
-35,173
-41,758
-36,526
-50,465
-42,804
Total other income/expenses net
109
4,809
1,171
-171
322
Income before tax
-35,064
-36,949
-35,355
-50,636
-42,482
Income from continuing operations
-35,064
-36,949
-35,355
-50,636
-42,482
Net income
-35,064
-36,949
-35,355
-50,636
-42,482
Net income available to common shareholders
-35,064
-36,949
-35,355
-50,636
-42,482
Basic EPS
-0.60
-0.84
-1.37
-2.95
-3.57
Diluted EPS
-0.60
-0.84
-1.37
-2.95
-3.57
Basic average shares
43,949
43,901
25,761
17,164
11,883
Diluted average shares
43,949
43,901
25,761
17,164
11,883